Does Aetna Cover Propecia? What You Need to Know About Insurance and Finasteride

Propecia is the brand name for oral finasteride 1 mg, a 5-alpha-reductase inhibitor approved by the FDA in 1997 specifically for male androgenetic alopecia (male-pattern hair loss). It is a different product from Proscar, which is finasteride 5 mg approved in 1992 for benign prostatic hyperplasia (BPH), same molecule, different dose, different FDA-approved indication, and, as a rule, a different insurance outcome.

The direct answer: most Aetna commercial, ACA marketplace, and Medicare Advantage/Part D plans do not cover Propecia or generic finasteride 1 mg when it is prescribed for androgenetic alopecia, because Aetna and federal Medicare rules both classify hair-loss treatment as cosmetic. Finasteride 5 mg for BPH is a separate, usually covered benefit under a different diagnosis code. The exclusion for hair loss is a general rule across plan types rather than a single Aetna-specific quirk, it also reflects a federal Medicare Part D exclusion for "drugs used for cosmetic purposes or hair growth." Because generic finasteride 1 mg is inexpensive at retail, the practical stakes of the coverage question are lower than they first appear.

The useful question for most readers is not "does Aetna cover this drug" in the abstract, but whether your specific plan document, diagnosis code, or self-funded employer benefit creates a narrow exception, and whether it's worth the time to find out given how cheap the generic already is without insurance.

Why hair-loss treatment is usually excluded

Aetna's publicly posted clinical policy materials treat androgenetic alopecia treatments, including finasteride and topical minoxidil, as cosmetic rather than medically necessary. Cosmetic exclusions are standard across commercial HMO, PPO, and POS benefit designs. This is a plan-design decision, not an FDA determination, finasteride 1 mg is FDA-approved for this exact indication, but "FDA-approved" and "insurance-covered" are separate questions, and insurers routinely decline to cover approved drugs they consider cosmetic. Confirm current policy language on Aetna's site for your specific plan, since policy bulletins can be updated.

How BPH coverage differs from hair-loss coverage

Finasteride 5 mg (Proscar) treats BPH, a urological diagnosis Aetna and most insurers consider medically necessary, and it is typically covered at a low generic copay tier. Finasteride 1 mg for hair loss is the identical drug class at a different dose and a different diagnosis code, and it does not receive that treatment. If a formulary search shows "finasteride" as covered, check the dose and the associated diagnosis, a hit on the 5 mg BPH listing does not mean the 1 mg hair-loss prescription will be covered. The FDA-approved labeling for each product describes the approved indication and dosing; current labels can be checked at FDA.gov.

Medicare Part D and Medicare Advantage

Medicare Part D law excludes drugs "used for cosmetic purposes or hair growth" from the statutory definition of a covered Part D drug. This is a federal exclusion, not a plan-specific one, so it applies across Aetna Medicare Advantage and Part D products regardless of formulary tier structure. General background on Part D coverage rules is available from CMS. Because this is a federal rule rather than an Aetna choice, appealing it at the plan level is unlikely to change the outcome for a straightforward androgenetic alopecia diagnosis.

ACA marketplace plans

Individual Aetna marketplace plans must cover Essential Health Benefits, but EHB categories do not require coverage of cosmetic medications, and state benchmark plans that define EHB generally do not include hair-loss drugs. Marketplace Aetna plans therefore follow the same exclusion pattern as commercial plans.

Self-funded employer plans

Large employers that self-insure through Aetna as a third-party administrator can customize formularies, and in theory a self-funded plan could add finasteride 1 mg as a covered benefit. This is uncommon, and there is no general source that can confirm whether your specific employer has done this, it has to be checked directly.

What is established, what is plausible, and what isn't confirmable from general sources

Established: Propecia (finasteride 1 mg) is FDA-approved for androgenetic alopecia; Proscar (finasteride 5 mg) is FDA-approved for BPH; Medicare Part D has a federal statutory exclusion for cosmetic/hair-growth drugs; generic finasteride is a low-cost, widely stocked generic medication.

Plausible but plan-dependent: a self-funded employer plan might cover finasteride 1 mg; a diagnosis other than androgenetic alopecia (autoimmune alopecia areata, PCOS-related hirsutism, gender-affirming hormone therapy) might route a finasteride claim differently under prior authorization.

Not established from public sources, and not something this article can confirm for you: the exact current cash price at any specific pharmacy, whether your particular Aetna plan has an exception, whether an appeal would succeed for your diagnosis, and any manufacturer discount program status, all of these change over time and require a direct, dated check.

How to check your specific Aetna plan

1. Log in to the Aetna member portal and search the pharmacy formulary for "finasteride." Note the dose listed (1 mg vs 5 mg) and any prior authorization or step therapy flags.
2. Call the pharmacy benefits number on your member ID card and ask specifically whether finasteride 1 mg is covered for the diagnosis of androgenetic alopecia. Ask for the denial reason in writing if the answer is no, a written denial is typically required to start a formal appeal.
3. Ask your prescriber's office to run a real-time e-prescribe benefits check, which can show formulary status and an estimated copay before you go to the pharmacy.

None of these steps can be done reliably from a general article, plan details are specific to your policy and change over time, which is why they're listed as verification steps rather than answered here.

Is an appeal worth trying?

Appeals against a cosmetic exclusion rarely succeed for a straightforward androgenetic alopecia diagnosis, because the exclusion is usually written explicitly into the plan document, and an external reviewer will generally uphold a denial that matches stated plan language. Appeals have a better, though still not guaranteed, chance when hair loss is a symptom of a separately covered medical condition, such as alopecia areata (an autoimmune condition), scarring alopecia associated with lupus or lichen planopilaris, or hirsutism linked to PCOS. In those cases, a medical necessity letter typically needs the specific ICD-10 code for the underlying condition (not androgenetic alopecia), relevant lab work, and any biopsy findings, submitted by the prescribing physician.

If both internal appeal levels are denied, ACA rules generally provide a right to an independent external review. For a pure androgenetic alopecia diagnosis, the external reviewer is likely to uphold Aetna's denial because the exclusion is a matter of plan language, not medical dispute.

Any claim about a named physician's public statement on appeals should be attributed to a specific, checkable source before publication. No such attributable quotation was available for this draft, so none is included.

Cost without insurance

Brand Propecia at retail commonly runs in the range commonly cited by pharmacies as roughly $90 to $120 for a 30-day supply, though this varies by pharmacy and changes over time, check a current price tool before relying on a number. Generic finasteride 1 mg is one of the least expensive prescription drugs sold in the United States; many discount programs and warehouse pharmacies list 30-day supplies well under $20, though exact prices are time-sensitive and pharmacy-specific and should be checked the same day you plan to fill the prescription.

Some prescribers discuss splitting finasteride 5 mg tablets to approximate the 1 mg hair-loss dose at lower cost. The FDA's general guidance on tablet-splitting notes that not all tablets are appropriate to split, and finasteride tablets are not scored for this purpose, so dose accuracy can vary. This should be discussed with a prescriber rather than done independently, and this general practice should be discussed with a prescriber rather than done independently, since not all tablets are appropriate to split.

What the clinical evidence shows about finasteride's effect on hair loss

Finasteride 1 mg is FDA-approved based on registration trials showing that treated men were more likely than those on placebo to maintain or increase hair count over roughly two years of continuous use. Longer follow-up studies have reported continued benefit for some patients over multiple years, with gradual attenuation of effect in others. Because the specific PubMed identifiers commonly attached to these trial statistics could not be independently verified for this draft, precise percentages and hair-count figures have been removed rather than restated with false confidence. Anyone who needs exact trial numbers for clinical decision-making should pull them directly from the current FDA label or a verified systematic review rather than from a secondary summary.

Side effects

The FDA-approved label for finasteride 1 mg lists sexual side effects, decreased libido, erectile dysfunction, and ejaculation disorder, occurring in a small percentage of treated men, somewhat above placebo rates. The FDA added label language in 2012 addressing reports of persistent sexual side effects after discontinuation. A syndrome of persistent symptoms after stopping finasteride ("post-finasteride syndrome") is described in patient reports and has been the subject of ongoing scientific discussion, but it is not a formally established diagnostic entity recognized by the FDA. Anyone considering finasteride should discuss the current label warnings and their own risk factors directly with a prescriber rather than relying on a secondary summary of trial statistics.

Alternatives and their coverage status

Topical minoxidil is available over the counter in 2% and 5% formulations. Because it is OTC, it is not processed through prescription pharmacy benefits regardless of insurer.

Low-dose oral minoxidil, prescribed off-label for hair loss, is increasingly used in dermatology practice. If Aetna covers oral minoxidil at all, it is typically for its on-label indication (hypertension); off-label use for hair loss generally falls under the same cosmetic exclusion as finasteride.

Dutasteride (Avodart) is FDA-approved only for BPH, not for hair loss. Some dermatologists prescribe it off-label for androgenetic alopecia. Aetna coverage, where it exists, is tied to the BPH indication, not the off-label hair-loss use.

Platelet-rich plasma (PRP) injections are treated as a cosmetic procedure by essentially all insurers, including Aetna, and are paid out of pocket.

When finasteride might be covered for a non-hair-loss reason

• BPH: finasteride 5 mg for an enrolled BPH diagnosis is the clearest covered pathway for this molecule.
• Gender-affirming hormone therapy: some Aetna plans that include gender-affirming care benefits may cover finasteride as part of a feminizing regimen; this depends on the specific plan and requires the correct diagnosis coding.
• Hirsutism/PCOS: finasteride is sometimes prescribed off-label for hirsutism in PCOS; coverage, where available, generally requires prior authorization and the PCOS diagnosis code rather than an alopecia code.

None of these pathways are guaranteed, and each depends on plan-specific rules that change over time.

If Aetna denies coverage

• Pharmacy discount programs (GoodRx-type platforms) and warehouse pharmacies often price generic finasteride 1 mg low enough that the insurance question becomes close to moot for this specific drug.
• HSA or FSA funds can generally be used for prescription medications even when a specific drug is not covered by the insurance plan, which effectively reduces the cost by your marginal tax rate, check your plan administrator's current rules.
• Telehealth prescribing services can bundle consultation and medication into a flat monthly price, removing the insurance variable, though pricing and services vary by vendor and change over time.

Verification checklist: what's stable vs. what you must check today

Use this to separate facts that are unlikely to change from facts that are date-sensitive and specific to your plan or pharmacy. Anything in the second column needs a fresh check before you rely on it.

Frequently asked questions